Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SCHLX vs HRTS overlap: 64% of top holdings shared

Bottom line

How much do SCHLX and HRTS overlap?

64% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 61.9% of SCHLX's assets and 55.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

SCHLXHRTS
Weight overlap (top 25)64%
Shared holdings16
Weight in shared holdings61.9%55.9%
Total positions6545
Expense ratio1.06%0.75%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings SCHLX and HRTS have in common

Holding% of SCHLX% of HRTSOverlap
Eli Lilly & Co13.85%11.52%11.52%
Johnson & Johnson6.19%3.59%3.59%
UnitedHealth Group Inc5.73%5.24%5.24%
AbbVie Inc4.90%2.40%2.40%
Merck & Co Inc4.85%4.27%4.27%
AstraZeneca PLC3.80%4.00%3.80%
Thermo Fisher Scientific Inc3.46%3.97%3.46%
Amgen Inc2.88%1.91%1.91%
Gilead Sciences Inc2.78%3.43%2.78%
Vertex Pharmaceuticals Inc2.45%2.93%2.45%
Abbott Laboratories2.39%2.61%2.39%
Danaher Corp2.13%2.66%2.13%
McKesson Corp2.05%1.71%1.71%
Medtronic PLC1.54%1.88%1.54%
Bristol-Myers Squibb Co1.50%2.09%1.50%
Regeneron Pharmaceuticals Inc1.43%1.67%1.43%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SCHLX

  1. Novartis AG — 2.90%
  2. Intuitive Surgical Inc — 2.69%
  3. Stryker Corp — 2.61%
  4. Boston Scientific Corp — 2.10%
  5. Novo Nordisk A/S — 1.73%
  6. Cardinal Health Inc — 1.34%
  7. Cencora Inc — 1.26%
  8. Roche Holding AG — 1.24%
  9. Pfizer Inc — 1.17%

Only in HRTS

  1. Novo Nordisk A/S — 5.24%
  2. Roche Holding AG — 4.50%
  3. Novartis AG — 3.38%
  4. Revolution Medicines Inc — 3.33%
  5. Bridgebio Pharma Inc — 2.59%
  6. Cytokinetics Inc — 2.52%
  7. Teva Pharmaceutical Industries — 2.06%
  8. Dexcom Inc — 1.92%
  9. Edwards Lifesciences Corp — 1.75%

Asset mix

Asset typeSCHLXHRTS
Stocks99.6%99.2%
Cash & short-term funds0.5%0.7%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountrySCHLXHRTS
US85.7%74.9%
CH5.2%7.9%
DK1.7%7.0%
GB3.8%4.0%
IL—2.1%
IE1.5%1.9%
JP—1.3%
FR1.0%—

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do SCHLX and HRTS overlap?
About 64% by weight. 16 securities appear in both funds' top 25 holdings; they make up 61.9% of SCHLX's assets and 55.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do SCHLX and HRTS have in common?
The largest shared holdings are Eli Lilly & Co, UnitedHealth Group Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson.
Should I own both SCHLX and HRTS?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, SCHLX or HRTS?
SCHLX is broader, with 65 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.